Skip to main content
. 2017 Jan 14;32(2):265–272. doi: 10.1093/ndt/gfw424

Table 2.

Summary of outcomes evaluated across included studies

Study Patient-related outcomes
Process of care outcomes
Health service use
Receipt of RRT Worsening AKI or change in creatinine Mortality Time to drug dose adjustment Medication review for nephrotoxins (discontinuation/ avoidance) Documented AKI in the medical record Nephrology consult Follow-up creatinine Administration of fluid, vasopressors or diuretic therapy Hospital LOS ICU LOS ICU admission ICU readmission
Rind [21] No Yes Yes Yes No No No No No Yes No No No
McCoy [22] No No No Yes Yes No No No No No No No No
Colpaert [11] Yes Yes Yes Yes Yes No No No Yes No Yes No No
Selby [23] No Yes Yes No No No No No No Yes No No No
Moran [24] No No Yes No No No No No No No No No No
Wilson [12] Yes Yes Yes No Yes Yes Yes Yes Yes Yes No No No

LOS, length of stay.

N/A = not available.